BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 17028502)

  • 1. Thyroid disease associated with exposure to the Nevada nuclear weapons test site radiation: a reevaluation based on corrected dosimetry and examination data.
    Lyon JL; Alder SC; Stone MB; Scholl A; Reading JC; Holubkov R; Sheng X; White GL; Hegmann KT; Anspaugh L; Hoffman FO; Simon SL; Thomas B; Carroll R; Meikle AW
    Epidemiology; 2006 Nov; 17(6):604-14. PubMed ID: 17028502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study of thyroid disease in relation to fallout from nuclear weapons testing.
    Kerber RA; Till JE; Simon SL; Lyon JL; Thomas DC; Preston-Martin S; Rallison ML; Lloyd RD; Stevens W
    JAMA; 1993 Nov; 270(17):2076-82. PubMed ID: 8411574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests.
    Gilbert ES; Tarone R; Bouville A; Ron E
    J Natl Cancer Inst; 1998 Nov; 90(21):1654-60. PubMed ID: 9811315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohort study of thyroid disease near the Nevada Test Site: a preliminary report.
    Rallison ML; Lotz TM; Bishop M; Divine W; Haywood K; Lyon JL; Stevens W
    Health Phys; 1990 Nov; 59(5):739-46. PubMed ID: 2211127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Utah Thyroid Cohort Study: analysis of the dosimetry results.
    Till JE; Simon SL; Kerber R; Lloyd RD; Stevens W; Thomas DC; Lyon JL; Preston-Martin S
    Health Phys; 1995 Apr; 68(4):472-83. PubMed ID: 7883559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a method to estimate thyroid dose from fallout radioiodine in a cohort study.
    Simon SL; Lloyd RD; Till JE; Hawthorne HA; Gren DC; Rallison ML; Stevens W
    Health Phys; 1990 Nov; 59(5):669-91. PubMed ID: 2211123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the National Cancer Institute's activities related to exposure of the public to fallout from the Nevada Test Site.
    Wachholz BW
    Health Phys; 1990 Nov; 59(5):511-4. PubMed ID: 2211110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid cancer risk in the population around the Nevada Test Site.
    Zeighami EA; Morris MD
    Health Phys; 1986 Jan; 50(1):19-32. PubMed ID: 3943971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposure to radioactive iodine and thyroid disease.
    Wilkinson GS
    Epidemiology; 2006 Nov; 17(6):599-600. PubMed ID: 17068412
    [No Abstract]   [Full Text] [Related]  

  • 10. A post-Chernobyl rise in thyroid cancer in Connecticut, USA.
    Mangano JJ
    Eur J Cancer Prev; 1996 Feb; 5(1):75-81. PubMed ID: 8664814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspective: National Cancer Institute summary report about estimated exposures and thyroid doses received from iodine 131 in fallout after Nevada atmospheric nuclear bomb tests.
    Hundahl SA
    CA Cancer J Clin; 1998; 48(5):285-98. PubMed ID: 9742895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of radiation exposures in Native American communities from nuclear weapons testing in Nevada.
    Frohmberg E; Goble R; Sanchez V; Quigley D
    Risk Anal; 2000 Feb; 20(1):101-11. PubMed ID: 10795343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of fallout in the continental U.S. from Nevada weapons testing based on gummed-film monitoring data.
    Beck HL; Helfer IK; Bouville A; Dreicer M
    Health Phys; 1990 Nov; 59(5):565-76. PubMed ID: 2211116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update.
    Gilbert ES; Huang L; Bouville A; Berg CD; Ron E
    Radiat Res; 2010 May; 173(5):659-64. PubMed ID: 20426666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thyroid cancer after exposure to 131I in childhood.
    Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
    J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening.
    Tronko MD; Howe GR; Bogdanova TI; Bouville AC; Epstein OV; Brill AB; Likhtarev IA; Fink DJ; Markov VV; Greenebaum E; Olijnyk VA; Masnyk IJ; Shpak VM; McConnell RJ; Tereshchenko VP; Robbins J; Zvinchuk OV; Zablotska LB; Hatch M; Luckyanov NK; Ron E; Thomas TL; Voillequé PG; Beebe GW
    J Natl Cancer Inst; 2006 Jul; 98(13):897-903. PubMed ID: 16818853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Thyroid cancer rates and (131)I doses from Nevada atmospheric nuclear bomb tests.
    Archer VE
    J Natl Cancer Inst; 1999 Aug; 91(16):1423-5. PubMed ID: 10451455
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid neoplasia, autoimmune thyroiditis, and hypothyroidism in persons exposed to iodine 131 from the hanford nuclear site.
    Davis S; Kopecky KJ; Hamilton TE; Onstad L;
    JAMA; 2004 Dec; 292(21):2600-13. PubMed ID: 15572718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCI apologizes for fallout study delay.
    Wadman M
    Nature; 1997 Oct; 389(6651):534. PubMed ID: 9335478
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thyroid cancer after Chernobyl: is iodine 131 the only culprit ? Impact on clinical practice].
    Guiraud-Vitaux F; Elbast M; Colas-Linhart N; Hindie E
    Bull Cancer; 2008 Feb; 95(2):191-5. PubMed ID: 18304904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.